| Element List | Current Quarter | Similar quarter for previous year | %Change | Previous Quarter | % Change |
|---|---|---|---|---|---|
| Sales/Revenue | 775,872,842 | 715,112,301 | 8.496 | 790,909,047 | -1.901 |
| Gross Profit (Loss) | 384,226,035 | 326,588,983 | 17.648 | 385,259,335 | -0.268 |
| Operational Profit (Loss) | 194,128,148 | 203,614,307 | -4.658 | 192,085,715 | 1.063 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 192,062,164 | 174,924,439 | 9.797 | 173,138,809 | 10.929 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 226,525,778 | 174,796,305 | 29.594 | 172,515,689 | 31.307 |
| All figures are in (Actual) Saudi Arabia, Riyals | |||||
| Element List | Current Period | Similar period for previous year | %Change |
|---|---|---|---|
| Sales/Revenue | 1,566,781,889 | 1,548,840,471 | 1.158 |
| Gross Profit (Loss) | 769,485,370 | 699,186,986 | 10.054 |
| Operational Profit (Loss) | 386,213,863 | 392,915,422 | -1.705 |
| Net Profit (Loss) Attributable to Shareholders of the Issuer | 365,200,973 | 346,795,535 | 5.307 |
| Total Comprehensive Income Attributable to Shareholders of the Issuer | 399,041,467 | 351,519,431 | 13.519 |
| Total Shareholders Equity (after Deducting Minority Equity) | 3,081,032,149 | 2,635,325,509 | 16.912 |
| Profit (Loss) per Share | 4.57 | 4.33 | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Amount | Percentage of the capital (%) | |
|---|---|---|---|
| Profit (Losses) Resulting From The Change In Investment Propertie’s Fair Value | – | – | |
| All figures are in (Actual) Saudi Arabia, Riyals | |||
| Element List | Explanation |
|---|---|
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the same quarter of the last year is | Sales increase in general due to:
Increase in Sales in Pharmaceuticals segment. While noting that there is decrease in Sales in Steel industries segment. |
| The reason of the increase (decrease) in the net profit during the current quarter compared to the same quarter of the last year is | Net profit Increases in general due to:
1. Increase in Gross Profit in all segments. While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual. |
| The reason of the increase (decrease) in the sales/ revenues during the current quarter compared to the previous one is | Sales decrease in general due to:
Decrease in Sales in Steel industries segment. |
| The reason of the increase (decrease) in the net profit (loss) during the current quarter compared to the previous one is | Net profit Increases in general due to:
1. Increase in Other income, net in Others segment. |
| The reason of the increase (decrease) in the sales/ revenues during the current period compared to the same period of the last year is | Sales increases in general due to:
Increase in Sales in Pharmaceuticals segment. |
| The reason of the increase (decrease) in the net profit during the current period compared to the same period of the last year is | Net profit Increases in general due to:
1. Increase in Gross Profit in all segments. While noting that during similar period last year, there were lower General and administrative expenses in Steel industries segment due to reversal of excess accrual. |
| Statement of the type of external auditor’s report | Unmodified conclusion |
| Comment mentioned in the external auditor’s report, mentioned in any of the following paragraphs (other matter, conservation, notice, disclaimer of opinion, or adverse opinion) | NA |
| Reclassification of Comparison Items | NA |
| Additional Information | Net Shareholders’ Equity at the end of the period was SR 3,080,392,221/- compared to SR 2,656,733,760/- at the end of the similar period last year with an increase of 16%. |